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Abstract
Introduction and objective. In Poland, lung carcinoma is the most frequent malignant neoplasm in men and the third 
most frequent in women. The neoplastic disease causes enormous psychic stress and may lead to depressive reactions. 
The purpose of this research was to assess the quality of life and the occurrence of depression in patients suffering from 
lung neoplasms and undergoing chemotherapy.  
Materials and method. The research covered 102 patients (test group TG) with lung carcinoma and undergoing chemotherapy. 
In the research, standardised questionnaires: EORTC‑QLQ‑C30, Beck Depression Inventory and a matrix developed by the 
researcher were applied. The control group (CG) consisted of 60 healthy people who were examined by the Beck Depression 
Inventory.  
Results. A highly statistically significant dependency was found (p<0.01) between the general quality of life and the 
occurrence of depression. 51.5% of those examined with a very low level of general quality of life had the symptoms of 
severe depression. Those examined who had a very high level of general quality of life did not have features of severe 
depression. A statistically significant dependency (p<0.01) was ascertained between the occurrence of depression and the 
health condition of those examined.  
Conclusions. Depression symptoms occur more frequently and with greater intensity in patients suffering from lung 
neoplasm, compared to the group of healthy people (p<0.01). A statistically significant connection between marital status, 
place of residence, and assessment of quality of life was found out (p<0.05).
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INTRODUCTION
Lung carcinoma is a serious problem on a global scale for 
contemporary medicine, and comes within the group of the 
most popular and worst prognosing neoplasms [1, 2].
In Poland, lung carcinoma is the most frequent malignant 
neoplasm in men, and the third most frequent in women [3]. 
About 90% of men and 80% of women fall ill with the disease 
as a consequence of cigarette addiction [4].
Although the data from the examination of the intensity 
of cigarette addiction testify that residents of rural areas 
in Poland smoke more, the total survival of patients with 
diagnosed lung carcinoma, however, from both urban and 
rural environments are similar and comparable to the 
European average [5].
Persons suffering from lung carcinoma, similarly to other 
oncological patients, have problems with the acceptance 
of their disease before beginning treatment. Apart from 
personal predispositions, a material role in the psychological 
reaction is played by personal symptoms and the period in 
which they occur. Lung carcinoma develops deceitfully and 
non-specific symptoms are neglected. With most patients, 
the disease is diagnosed when it is already at the stage of 
significant progress, which excludes the potential to suggest 
radical treatment to this group of patients [6]. At the moment 
of diagnosing, the patients feel it as a ‘condemnation’ and 
try to find the answer to the question ‘why me?’ – through 
an analysis of carcinoma disease history in the family, and 
in the professional environment. They have either a strong 
sense of guilt because of cigarette smoking or a sense of being 
wronged when they have never smoked. These reactions are 
accompanied by fear of the effects of the disease (in the social 
understanding: pain and dying), and the results of treatment 
(surgical, chemical or radiation) [7].
The patient’s life changes dramatically from the moment 
lung carcinoma is diagnosed. First of all, physical fitness 
is reduced, then family and social contacts are limited (in 
particular for those who are hospitalised), a feeling of loss 
of a part of oneself (in the case of an operation), and mental 
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discomfort, most frequently of the nature of depressive or 
fright reaction. Because of the specific stereotype of social 
thinking, associating the diagnosis with death in pain, the 
carcinoma inflicts an enormous psychic stress and may 
lead to depressive reactions, even when it does not cause 
nagging, physical ailments, and does not limit motor or 
social activities. Patients going through depression develop 
also a sense of guilt for their condition and helplessness in the 
difficult situation. Their negative assessment of the previous 
life prevails, they are no longer interested in anything, and are 
under an oppressing sense of helplessness and hopelessness 
which reduces significantly their quality of life. The treatment 
for depression in the case of carcinomous disease is very 
important, as its final effect may be the patient’s giving up 
any further oncological treatment, worse relations with the 
family and medical personnel, and also suicidal attempts 
[8]. The main purpose of the research. The Objective. The 
primary aim of the study was to assess the quality of life and 
the occurrence of depressive disorder in patients suffering 
from the lung cancer and undergoing chemotherapy. 
Additionally, assessment of the occurrence and intensity of 
the depressive disorder in the patients depends on the period 
of chemotherapeutic treatment, age of the patients, place of 
residence, gender and education.
MATERIALS AND METHOD
The research was conducted in two groups of patients (TG 
and CG) and covered 102 patients (test group TG) with 
diagnosed lung carcinoma in various degrees of progress, 
hospitalised in the Pulmonological Ward and Ward for 
Palliative Care and Chemotherapy in the Independent Public 
Hospital in Kraśnik, south-east Poland, during the period 
from June 2010 – March 2011.
The control group (CG) consisted of 60 healthy people, 
who were tested by Beck Depression Inventory. Currently, 
they were not being treated for any chronic somatic or 
psychic disease. The basis to qualify to this group was a 
detailed health interview, excluding oncological history, as 
well as diseases with a distinct psychosomatic background. 
Participation in the research was voluntary and anonymous. 
The tests were conducted after a positive opinion was given 
by the Bioethical Commission at the Medical University of 
Lublin.
Standardised questionnaires: EORTC-QLQ-C30 (version 
3.0) (European Organization for Research and Treatment 
of Cancer Core Questionnaire) [9], the Beck Depression 
Inventory (BDI) [10] and the matrix of the researcher’s own 
authorship were applied.
The EORTC-QLQ-C30 (version 3.0) questionnaire – serves 
to examine the summary sense of being healthy and the 
assessment of physical, emotional and social functioning of 
patients suffering from cancer. It is the most frequently used 
tool to measure the quality of life related to health among 
patients with lung carcinoma, and used widely in clinical 
research on new drugs [11].
The questionnaire contains 30 questions grouped according 
to scales of functioning assessment (physical, in social roles 
and at work, cognitive, emotional and social), the impact of 
symptoms on the quality of life (pain, tiredness, nausea and 
vomiting, dyspnea, insomnia, loss of appetite, constipation 
and diarrhea), impact of the disease on the financial situation, 
and measurement of the general quality of life and general 
health condition [12,13]. For the purposes of the research, 
elements of the EORTC-QLQ-C30 questionnaire were used 
in the scope of general quality of life measurement and 
general condition of health.
The Beck Depression Inventory serves to assess the presence 
and intensity of symptoms of depression. Developed by an 
American psychiatrist, Aaron Temkin, the Beck inventory 
was published in 1961. The inventory is composed of 21 
items related to the most frequently observed depression 
symptoms: depressed mood, pessimism, self-accusations, 
loss of satisfaction, sense of guilt, need to be punished, 
self-dissatisfaction, inferiority complex, suicidal thoughts, 
weeping, nervousness, loss of interest in others, difficulties in 
making decisions, negative picture of own body, loss of ability 
to work, sleep disorders, tiredness, loss of appetite, loss of 
body weight, worrying about one’s own health, and loss of sex 
drive. Within each category there are four possible answers 
which define the intensity of a given symptom, starting 
from its non-existence, up to a very significant intensity 
(0–3 points) [10].
A standard key to EORTC-QLQ-C30 (3.0) questionnaires 
was used for analysis together with templates standardising 
the results in the scale from 0–100. In the questions about 
the health condition and the quality of life, the answers are 
given in the scale from 1 (‘very bad’) up to 7 (‘perfect’), and 
a higher point value means a better assessment of the health 
condition and the quality of life. Similarly, in the general 
assessment of the quality of life, a higher point result means 
a better total assessment of the quality of life. In the case of 
general assessment of quality of life, it was assumed that the 
point result in the global scale of the quality of life should be 
assessed according to a 4-degree scale in the following way: 
0–25 points – very low quality of life, 26–50 points – low 
quality of life, 51–75 points – high quality of life, 76–100 
points – very high quality of life. Additionally, the arithmetic 
average was applied to the severe scale 1–7 where 1 meant the 
lowest assessment, and 7 the highest one [9,12,13].
The level of depression was calculated according to various 
standards (for instance, the German standard or American 
standard). In this research, the following interpretation of 
results was adopted: 0–9 points – no depression nor mood 
lowering, 10–27 points – moderate depression, 28 and more 
points – severe depression [12].
Per cent indicators were also applied to a detailed 
description of questions, making up individual scales. To test 
statistically significant dependences between the variables, 
the Chi-square test was used. The test probability at a level 
p<0.05 was assumed as material, and the test probability of 
p<0.01 as very significant. The results were analysed with the 
help of SPSS 14.0 PL software for Windows.
Characteristics of the tested group. The clinical group 
consisted of 102 patients treated for lung carcinoma. They 
all had the result of a histopathological test confirming the 
diagnosed carcinoma, and were hospitalised for at least 14 
days. Most of them were men (51.0%). The average age of 
those examined was 53.68±12.18 years. The biggest group 
consisted of respondents aged between 51–60 (32.4%), the 
least numerous group of patients was aged between 18–30 
(3.9%). 44.1% of those tested had college education, and 
15.7% university education. A decisive majority of those 
tested were married (73.5%), the fewest of them declared to 
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be bachelors/spinsters (11.8%). They resided in towns (54.9%). 
They had college (44.1%) or lower (40.2%) education. 84.3% 
lived with the family. In the group of those who were sick, 
a larger proportion of pensioners and disability pensioners 
(64.7%) was found than in other groups. A little over two-
thirds of those tested (67.6%) assessed their material situation 
as average. All those tested (100.0%) were undergoing 
chemotherapy. The average period of taking cytostatic drugs 
in the patient group was 6.36 months. The largest number of 
those tested (72.5%) took cytostatic drugs for a period shorter 
than half a year. The least numerous were the patient group 
who took cytostatic drugs for a period ranging from 13–18 
months (2.0%) and more than 24 months (2.0%).
Detailed data related to the socio-demographic features 
are presented in Table 1.
RESULTS
The general quality of life was assessed in the population of 
lung carcinoma patients. The indicators of this value were 
composed of questions in which the respondents assessed 
subjectively their general condition of health and quality of 
life. Through assessing the general quality of life, the total 
arithmetic average of 3.565 was obtained, and in the case of 
health condition assessment – 3.57. The average point result in 
the total scale of the quality of life of those under examination 
was 42.73±18.38 (mediana 50.00), which means low quality 
of life of the patients examined. The lowest general quality of 
life (0) was declared by two patients (2.0%), and the highest 
(100) by one person (1.0%).
Analysis of the research material allowed familiarisation 
with the occurrence and intensity of depression symptoms 
amongst 102 patients with diagnosed lung cancer (TG), and 
comparison with the control group (CG). The results obtained 
in the Beck Inventory were correlated with the results of the 
measurement of the general quality of life of the patients.
Among those examined with a very low level of general 
quality of life, 51.5% showed symptoms of severe depression, 
whereas among those examined with a very high level of 
general quality of life, no features of severe depression were 
revealed. The distribution of answers and the results of the 
Chi-square tests indicate a highly statistically significant 
dependence (p<0.01) between the general quality of life and 
the occurrence of depression. In the control group (CG) no 
statistically significant differences were indicated (Tab. 2).
Examining 102 lung carcinoma patients from the viewpoint 
of depressive tendencies, these tendencies were measured 
among 60 healthy, working and studying people, and then 
compared with the results of the sick. The structure of the 
test group from the viewpoint of depressive tendencies is 
presented in Graphs 1 and 2.
Among 162 people examined with the use of Beck 
Depression Inventory, 38.9% of those examined did not 
show depression or lowered mood, 38.3% had features of 
moderate depression and 22.8% had symptoms of severe 
depression (Tab. 3).
The research indicated that among the patients, the 
largest per cent (43.1%) constituted people with symptoms 
of moderate depression. The symptoms of severe depression 
were revealed in 32.4% of the examined patients. In the 
healthy group. no features of depression were found out 
in 93.3 % of those examined, however, the symptoms of 
moderate depression were shown by 6.7% of respondents. A 
highly statistically significant dependence (p<0.01) between 
the occurrence of depression and the health condition of 
those examined was revealed (Tab. 4).
The general quality of life was examined in the group of 
the sick and in the group of the healthy. Assessing the general 
quality of life, a global arithmetic average was obtained of 
3.56. A slightly higher average indicator was noted in the case 
of health condition assessed as 3.57. Assessing the quality of 
life of those examined, owing to the application of raw results 
Table 1. Demographic variables in tested groups
Socio‑demographic factors
Tested population
pTG CG
Gender N % N %
Female 52 51 28 47 p=0.762
χ2 = 0.09
Male 50 49 32 53 p=0.766
χ2 = 0.9
AGE
Age 18–30  4 3.9  4 6.6 p=0.546
χ2 = 0.36
Age 31–40  8 7.8 10 16.7 p=0.110
χ2 = 2.56
Age 41–50 30 29.4  9 15 p=0.050
χ2 = 3.84
Age 51–60 33 32.4 12 20 p=0.1272
χ2 = 2.33
Age 51–60 27 26.5 25 41.7 p=0.092
χ2 = 2.84
EDUCATION
Elementary/vocational 41 40.2 18 30 p=0.282
χ2 = 1.16
Secondary 45 44.1 23 38.3 p=0.581
χ2 = 0.30
University 16 15.7 19 31.7 p=0.304
χ2 = 4.69
CIVIL STATUS
Bachelor/spinster 16 15.7 18 30.0 p=0.055
χ2 = 3.67
Married 71 69.6 29 48.3 p=0.053
χ2 = 3.74
Single 15 14.7 13 21.7 p=0.324
χ2 = 0.97
PLACE OF RESIDENCE
Town 56 54.9 38 63.3 p=0.519
χ2 = 0.42
Village 46 45.1 22 36.7 p=0.439
χ2 = 0.60
RESIDING
On their own 16 15.7 18 30 p=0.055
χ2 = 3.67
With the family 86 84.3 42 70 p=0.295
χ2 = 1.10
SOURCE OF INCOME
Employment 26 25.5 26 43.3 p=0.054
χ2 = 3.71
Disability pension/old age pension 66 64.7 28 46.7 p=0.108
χ2 = 2.58
)ther 10 9.8  6 10 p=0.823
χ2 = 0.05
Source: Own data based on research
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standardisation by their transformation to a 100 point scale, 
ranging from 0–100, an average of 42.73 was obtained with 
the standard deviation ± at a level of 18.38, medina 50.00, 
and range from 0–100 points. The results indicate a low 
level of general quality of life (Graph 3). For the purposes 
of analysis, the quality of life was assessed depending upon 
socio-demographic factors: age, civil status and residence. 
Statistical analysis of the examined variables did not show 
statistically significant differences in the general assessment 
of quality of life and age of those examined (Tab. 5).
Analysis showed that there was a statistically significant 
difference (p<0.05) in the results of the quality of life 
measurement and marital status. In the case of unmarried 
(single) people, in 37.0% of cases, a very low level of general 
Table 2. General quality of life in the examined group and the symptoms 
of depression
Level of general 
quality of life
Depression disorder
Total
Chi‑
square
No depression 
nor depressed 
mood
Moderate 
depression
Severe 
depression
Very 
low
TG
N  1  1 17  19
*
% 4.0  2.3  51.5  18.6
CG
N  3  1 0   4
% 6.1   9.1 0   6.7
Low
TG
N 15 36 13  64
*
% 60.0  81.8  39.4  62.7
CG
N 19  6 0  25
% 38.8  54.5 0  41.7
High
TG
N  7  6  3  16
*
% 28.0  13.6   9.1  15.7
CG
N 21  3 0  24
% 42.9  27.3 0  40.0
Very 
high
TG
N  2  1 0   3
% 8.0   2.3 0   2.9
*
CG
N  6  1 0   7
% 12.2   9.1 0  11.6
General
TG
N 25 44 33 102 χ2 = 
40.462
df = 6
p < 0.0001
% 100.0 100.0 100.0 100.0
CG
N 49 11 0  60
% 100.0 100.0 --- 100.0
* – statistical significance of depression disorder in individual profiles between tested group 
(TG) and control group (CG) p<0.05.
Source: own data based on research
120%
100%
80%
60%
40%
20%
0%
CGTG
no depression nor lowered mood
moderate depression
severe depression
TG + CG N = 162
120%
100%
80%
60%
40%
20%
0%
no depression nor lowered mood
moderate depression
severe depression
Figure 3. General quality of life
Source: own data based on research
Figure 1. Depression disorder in test group vs. control group
Source: own data based on research
Figure 2. Group structure
Source: own data based on research
Table 3. Level of depression in the tested group
DEPRESSION 
DISORDER
Tested population
pTG CG
N % N %
No depression nor 
lowered mood
63 38.9 56 93.3
p=0.003
χ2 = 8.78
Moderate depression 62 38.3  4  6.7
p<0.0001
χ2 = 20.0
Severe depression 37 22.8  0 0 ‑‑‑
Source: own data based on research
Table 4. Condition of health and depression
Condition of depression 
Condition of 
health Total Chi‑square 
Healthy Sick
Without depression 
nor lowered mood
N 38  25  63 χ2 = 27.259
% of health condition  63.3  24.5  38.9 df = 2
 Moderate 
depression
N 18  44  62 p < 0.0001
% of health condition  30.0  43.1  38.3
Severe depression
N  4  33  37
% of health condition   6.7  32.4  22.8
Total
N 60 102 162
% of health condition 100.0 100.0 100.0
Source: own data based on research
6
5
4
3
2
0.0%    10.0%      20.0%    30.0%     40.0%      50.0%
very bad
excellent
Assessment of quality of life
Assessment of general condition of health
Table 5. Age and level of general quality of life of those examined.
Age 
Level of general quality of life
General 
Chi‑
squareVery low Low High Very high
Up to 60 
years
N 10 45 14 2  71 χ2 = 5.037
% age 14.1 63.4 19.7 2.8 100.0 df = 3
 Over 60 
years
N  9 19  2 1  31 p = 0.169
% age 29.0 61.3 6.5 3.2 100.0
Total 
N 19 64 16 3 102
% age 18.6 62.7 15.7 2.9 100.0
Source: own data based on the research
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quality of life was discopvered, and in the case of those who 
were married – in 12.0% of cases. A prevailing group in the 
synthetical categories of marital status consisted of those 
with a low level of general quality of life (Tab. 6).
In the case of dependency between place of residence and 
general quality of life, a statistically significant difference 
(p<0.05) was found in the results of quality of life measurement 
due to the residence of those examined. In the case of people 
living on their own, in 50.0% of cases a very low level of 
quality of life was discovered. In the case of people residing 
with the family, only 12.8% of respondents had the lowest 
level of quality of life (Tab. 7).
Period of taking cytostatic drugs and the intensity of 
depression symptoms. During the analysis of the research, 
the dependency between the level of depression and the 
period of taking cytostatic drugs was checked. For this 
purpose, analysis was made of the correlation between the 
indicator of depression level and the period of chemotherapy.
It turned out that there was no statistically significant 
difference (p>0.05) in the results of the quality of life 
measurement with regard to the period cytostatic drugs were 
taken. Detailed results for each time span reflect the general 
tendencies in the examined population (Tab. 8).
DISCUSSION
Lung neoplasms make up a non-uniform group from the 
histological and clinical aspects. The clinical-pathological 
division runs between non-small cell lung carcinoma 
(NSCLC), which makes up about 80%, and small cell lung 
carcinoma (SCLC) which makes up the remaining 20%. In 
the author’s research, the average results of the general quality 
of life of lung neoplasm patients treated by chemotherapy 
was 3.56, and in the case of the assessment of their health 
condition – 3.57. Nowicki et al. examined with the use of 
the EORTC-QLQ-C30 questionnaire the general quality 
of life and the general condition of health in a group of 
29 patients treated surgically for lung cancer. The average 
results thus obtained were a little higher than in the author’s 
research, and amounted to 3.90 for the global assessment 
of the quality of life and 3.83 for the general assessment of 
health condition [14]. Similarly, Zielińska-Więczkowska and 
Betłakowski in studies conducted with the use of the EORTC-
QLQ-C30 questionnaire in a group of 105 neoplasm patients 
during chemotherapy, obtained higher average results for the 
general quality of life and general condition of health, which 
amounted correspondingly to 4.03 and 3.90 [15].
The diagnosis of lung cancer and the symptoms related 
to it, together with the therapy, worsen the quality of life of 
patients – Larsson et al. proved clinically and statistically, 
significant differences in the area of nearly all elements of the 
scale related to the symptoms and functioning of the EORT-
QLQ–C30 questionnaire, between the group of the sick with 
non-small cell lung carcinoma and the general population 
[16]. In the author’s data, a highly statistically significant 
reverse dependency (p<0.01) between the general quality of 
life and the level of depression was ascertained – the worse the 
quality of lung carcinoma patients life, the bigger the intensity 
of depression symptoms. In the examined group with a very 
low level of general quality of life, as much as 89.5% showed 
symptoms of severe depression. Among those examined with 
a very high level of general quality of life, none of the patients 
showed symptoms of severe depression. Similarly, Mess et al., 
in the research conducted in a group of 50 patients with lung 
carcinoma, ascertained the existence of a strong negative 
correlation between the level of depression in the Zung scale 
and the general quality of life assessed according to the 
Table 7. Residence and level of general quality of life of those examined.
Residence 
Level of general quality of life
Total Chi‑squareVery 
low
Low High
Very 
high
Alone
N  8  8  0  0  16 χ2 = 14.053
% from residence 50.0 50.0  0  0 100.0 df = 3
With  
family 
N 11 56 16  3  86 p = 0.003
% from residence 12.8 65.1 18.6 3.5 100.0
Total 
N 19 64 16  3 102
% from residence 18.6 62.7 15.7 2.9 100.0
Source: own data based on the research
Table 6. Marital status and level of general quality of life of those 
examined
Marital status 
Level of general quality of life
Total
Chi‑
squarevery low low High very high
Un‑
married
N 10 15 2 0 27 χ2 = 9.668
% marital status 37.0 55.6 7.4 0 100.0 df = 3
Married
N 9 49 14 3 75 p = 0.02
% marital status 12.0 65.3 18.7 4.0 100.0
Total 
N 19 64 16 3 102
% marital status 18.6 62.7 15.7 2.9 100.0
Source: own data based on the research
Table 8. Period of cytostatic drugs taking and the level of general quality 
of life of those examined
 Period of cytostatic drugs taking
Level of depression
Total 
Chi‑
squareVery 
low
Low High
Very 
high
Up to 6 
months 
N 11 49 11 3  74 χ2 = 8.497
% period of cytostatics 
taking 
14.9 66.2 14.9 4.1 100.0 df = 12
7 ‑ 12 
months
N  5 10  4 0  19 p = 0.745
% period of cytostatics 
taking
26.3 52.6 21.1 0 100.0
 13 ‑ 18 
months
N  0  1  1 0   2
% period of cytostatics 
taking
0 50.0 50.0 0 100.0
 19 ‑ 24 
months 
N  2  3  0 0   5
% period of cytostatics 
taking
40.0 60.0  0 0 100.0
 Longer 
than 24 
months
N  1  1  0 0   2
% period of cytostatics 
taking
50.0 50.0  0 0 100.0
Total
N 19 64 16 3 102
% period of cytostatics 
taking
18.6 62.7 15.7 2.9 100.0
Source: own data based on the research
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checklist of the RSCL (Rotterdam Symptom Checklist) [13]. 
In turn, Arrieta et al., in their prospective study confirmed a 
statistically significant correlation between the degree of fear 
and intensity of depression among patients with advanced, 
non-small cell lung carcinoma, and a reduction in the results 
of quality of life in the questionnaire. Additionally, the 
authors noticed that the patients with depression showed 
significant shorter periods of total survival, compared to 
those patients who had no depressive disorder [17]. Research 
of Szymczak showed no statistically significant difference in 
the intensity of depressive symptoms assessed by the Beck 
Depression Inventory in a group of 37 patients with lung 
carcinoma waiting for torraco-surgical treatment, and in a 
group of 32 healthy people [18].
In the author’s own examination, patients with lung 
carcinoma show depressive tendency much more frequently 
than healthy people assessed by the Beck Depression 
Inventory. Among patients with lung carcinoma, the features 
of severe depression were discovered in 32.4%, moderate 
depression in 43.1%, and no depression in 24.5% of those 
examined. Among the healthy people examined, a result 
indicating severe depression was revealed in 6.7% and 30% 
showed moderate symptoms of depression; no features of 
depression were revealed in 63.3%. A highly statistically 
significant dependency (p<0.01) was revealed between the 
start of health of the respondents and the occurrence of 
symptoms of depression.n
Conflicting results were obtained by Zielińska-
Więczkowska and Betłakowski in research conducted in a 
group of 105 patients with carcinoma under chemotherapy, 
where the average results of self-assessments according to 
Zung depression scale were 35.20±8.81 (min. 20, max. 58 
points). In the research discussed, 93.3% patients had no 
psychopatological symptoms, moderate depression occurred 
in 6.7% of those examined, and no case of severe depression 
was found [19].
Mess et  al., in their research on a group of 50 patients 
with lung carcinoma, found the occurrence of symptoms 
of light depression, according to Zung scale, in 23 people 
(46.0%) of those examined [13]. In another paper, Mess 
et  al., in a group of 50 patients in the terminal stage of 
cancer, assessed by the Zung depression scale, showed the 
occurrence of light depression in 40.0% of those examined, 
moderate in 30.0%, and severe in 4.0% of the patients [20]. 
Nowicki and Rządkowska in a group of 100 patients with 
malignant cancer, using their own questionnaire based on 
Beck Depression Inventory, found in 36% the lowering of 
mood of light intensity, in 4% – depression of light intensity, 
and in only 1% – severe depression, and in 59.0% there were 
no symptoms of depression [21]. Other sources indicate 
the occurrence of depression symptoms in over 98.0% of 
patients suffering from lung carcinoma, which means a 
reduction in the quality of life in this group of patients [22]. 
In other publications, the occurrence of variously intensified 
depression symptoms were proved in 15.0%-44.0% of the sick 
after being diagnosed with lung carcinoma [23]. Results of 
the research obtained by Sharp and Strong indicate that this 
disorder is diagnosed in only 49.0% of oncological patients 
suffering from depression. In 42.0%, treatment for depression 
is administered, which proves to be efficient in only 15.0% 
of patients [24].
In the research dealing with the problems of the occurrence 
of depression in the group of patients with lung carcinoma, 
a strong connection is indicated between the depression 
and the personal features and way of coping with stress. To 
identify quickly the bio-psychosocial factors of depression 
risk, screening tests become helpful, for instance, the Hospital 
Anxiety and Depression Scale (HADS) [25].
CONCLUSIONS
1. The quality of life of patients with lung carcinoma is lower 
compared to the group of healthy people. Carcinoma 
disease has a negative impact on the physical, mental and 
social functioning of the patient.
2. The lower quality of life of patients with lung carcinoma 
has an impact on the bigger intensity of the symptoms of 
depression (p<0.01).
3. Depression symptoms occur more frequently and with 
bigger intensity in patients with lung carcinoma, compared 
to healthy people (p<0.01).
4. A statistically significant correlation has been proved 
between marital status, place of residence, and assessment 
of the quality of life (p<0.05). People residing with the 
family and are married declare a higher quality of life 
compared to solitary persons.
5. The period of taking cytostatic drugs had no impact on 
the level of depression in those examined.
6. Diagnosing cancer is linked to negative emotions, which 
justifies the application of simple tools to assess the 
occurrence and intensity of the symptoms of depression.
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